Cochlear
|
319.42 |
|
2.42 |
0.76% |
-6.99% |
2025-07-29 |
CSL
|
272.00 |
|
1.41 |
0.52% |
-12.06% |
2025-07-29 |
Integral Diagnostics
|
2.72 |
|
0 |
0% |
12.86% |
2025-07-29 |
Mesoblast
|
2.49 |
|
0 |
0% |
147.76% |
2025-07-29 |
Medical Developments International
|
0.65 |
|
-0.02 |
-2.26% |
54.76% |
2025-07-29 |
Mayne Pharma
|
5.02 |
|
-0.23 |
-4.38% |
17.84% |
2025-07-29 |
Neuren Pharmaceuticals
|
16.70 |
|
0.22 |
1.34% |
-13.87% |
2025-07-29 |
Paradigm Biopharmaceuticals
|
0.40 |
|
0 |
0% |
53.85% |
2025-07-29 |
Pacific Edge
|
0.10 |
|
-0.002 |
-1.96% |
9.89% |
2025-07-29 |
Polynovo
|
1.23 |
|
-0.02 |
-1.21% |
-52.52% |
2025-07-29 |
PYC Therapeutics
|
1.26 |
|
-0.01 |
-0.40% |
32.11% |
2025-07-29 |
Ramsay Health Care
|
38.79 |
|
-0.05 |
-0.13% |
-13.67% |
2025-07-29 |
ResMed
|
41.62 |
|
-0.08 |
-0.19% |
31.92% |
2025-07-29 |
Sonic Healthcare
|
28.19 |
|
-0.03 |
-0.11% |
3.53% |
2025-07-29 |